CorrectSequence Therapeutics
Shanghai
About CorrectSequence Therapeutics
CorrectSequence Therapeutics is a clinical-stage biotech company for next-generation gene editing therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Angel (Jan 2021)
- Website: correctsequence.com?lang=en
Industries & Categories
Biotechnology, Genetics
Canonical: https://fsome.com/organization/correctsequence-therapeutics-73359 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.